Volume 5 - Issue 4
Featured Content from The Arthritis & Glucosamine Resource Center
Check out Arthritis and Glucosamine Information!
Lastest news and articles about Arthritis and Glucosamine. www.arthritis-glucosamine.net
New Clinical Studies Confirm It
We have been telling our readers for years about the power of products like Syn-flex®. The recently completed GAIT studies have confirmed it. That is certainly more good news for those of you who suffer from Osteoarthritis.
The long-anticipated results are now out and this important study confirms that when used in combination, Glucosamine and Chondroitin outperformed other pain relievers for arthritis sufferers.
The study involved 1,583 participants at 16 U.S. rheumatology centers working under the guidance of the National Institutes of Health. (NIH) Each of them had OA of the knee.
MODERATE TO SEVERE OA PAIN
Most of you suffer from “moderate to severe” arthritis pain. This study made it clear that in that category of OA patients, these supplements provided significant pain relief to 79.2% of those studied. In fact, they were more effective than Celebrex®. That speaks volumes about the power of products like Syn-flex®.
*In fact, a close look at these studies showed that Glucosamine and/or
Chondroitin beat out Celebrex® in 12 of 14 outcomes reported. That is
Safety and Results
In 2005, both Vioxx® and Bextra® were withdrawn from the market. Prescription medications like Celebrex® remain under very close scrutiny. As well, federal regulators also began cautioning against the use of very common over-the-counter pain remedies.
There are sound reasons for that. The adverse consequences of using those products are well documented and it should be of concern to all of you.
You want pain relief. You want to get it without side effects. There is the issue of rehabilitation of cartilage that has broken down and continues to deteriorate. That is, it does if you do not use a high-quality Glucosamine/Chondroitin formula. Plus, the GAIT study also confirmed that both ingredients together outperformed either standing alone.
A Thirty-Year Plus History of Success
The GAIT study is just one of over 30 worldwide studies of the effectiveness of Glucosamine and/or Chondroitin. Glucosamine is considered a prescription medication or over-the-counter drug in 56 countries. Chondroitin is treated in a like manner in 22 countries. In many of these countries, they are reimbursed or subsidized by insurers. In fact, in the European Union provides a highest level of recommendation for OA sufferers. Those recommendations are made over and above any recommendation for drugs like Celebrex®.
The United States Could Learn from These Lessons
It is unfortunate that the United States has not come to the same level of acceptance as the EU. At some point in time, it may happen. In the meantime, just be aware that what we have had to say over the years has again been confirmed. This comes from another highly-respected medical authority.
See you next time.
Arthritis Message Board
Healthy Foods in Fighting Arthritis
8 Tips to Control Arthritic Pain
These past months in The Arthritis Chronicle, I've talked about my Eight Day Arthritis Ecourse that I had written. I had originally intended to give this informational course away free for only one issue, but due to the tremendous response and good word of mouth this course has brought, I have decided to give it away at no charge.
This Arthritis Course is packed with quality information on what you should know before you talk to your doctor, the arthritis diagnosis, treatment options, treatment side effects, glucosamine, tips on proper diets and exercise, weight management, alternative options, and an easy to understand explanation of what exactly arthritis is, how it occurs, and the effect on cartilage including a discussion of chondrocytes, collagen, proteoglycans, glycosaminoglycans, and synovial fluid.
If you are committed to taking the right steps towards effectively easing arthritis pain and knowing all your options, then this course will be extremely helpful to you.
The course is spread out over an eight day period and a new part of the course is sent each day right to your email inbox.
Once you begin your course above, you will receive one article each day delivered right to your email inbox. The daily topics are:
See You Next Month
This concludes the April Issue of The Arthritis Chronicle. Look for the next issue in your inbox on May 1st. Please forward to any friends you know who have arthritis and would be interested.
You have received the Arthritis Chronicle because you have subscribed to it (or it was forwarded to you by a friend). At any time, you may subscribe or unsubscribe here.
Would you like to be a contributing writer?
For comments and questions relating to The Arthritis Chronicle you may email firstname.lastname@example.org
This newsletter may be republished article by article or in whole as long as credit is given to author and link is provided to http://www.arthritis-glucosamine.net/
Have a great April from the Arthritis Chronicle
Synflex America Copyright ® 2001-2005
The statements herein have not been evaluated by the Food and Drug Administration. (FDA)
These products are not intended to diagnose, treat, cure or prevent disease.